AlphaMadera's AlphaVal page computes Concentrix Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag CNXC as undervalued, fairly valued, or overvalued.

What is Concentrix Corporation's fair value?

Fair value for CNXC is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value CNXC?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from CNXC's most recent reported fundamentals.

CNXC - Concentrix Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $35.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: CNXC revenue per share ($161) is 6x the stock price ($25.33). Financials likely reported in a foreign currency.